Where does Christine Martin work?

Christine Martin is Head of Ventures at University of Cambridge Enterprise.

What does Christine Martin invest in?

Christine Martin invests in Biotech, Deep Tech.

What companies has Christine Martin invested in?

Investments tracked here include Carrick, PhoreMost, PolyProX, Qkine, STORM, Z-factor.

Where did Christine Martin go to school?

Christine Martin studied at University of Oxford (MA, DPhil, Chemistry).

Christine Martin

Investor

Head of Ventures at University of Cambridge Enterprise

Greater Cambridge Area

About

Christine Martin is Head of Ventures at Cambridge Enterprise, overseeing investment activities with a focus on life sciences and drug discovery, and has backed University of Cambridge spin-outs including PhoreMost and Qkine. She joined in 2011 after roles in life sciences tech transfer and 11 years at biotech spin-out Biotica, and holds an MA and DPhil from the University of Oxford.

Contact· self-published, not guessed

c•••@enterprise.cam.ac.ukreveal

Invests in

BiotechDeep Tech

Experience

Cambridge EnterpriseHead of Venturescurrent2021 — presentCambridge, England, United Kingdom
Cambridge EnterpriseDeputy Head of Seed Funds2020 — 2021Cambridge, England, United Kingdom
Cambridge EnterpriseHead of Life Science Investment2019 — 2020Greater Cambridge Area
Cambridge EnterpriseActing Head of Seed Funds2020
Cambridge EnterpriseInvestment Manager (Life Sciences)2017 — 2019Greater Cambridge Area
Cambridge EnterpriseManager, Drug Discovery2012 — 2017
Cambridge EnterpriseSenior Technology Associate2011 — 2012
SDS TherapeuticsDirectorcurrent2020 — present
SpireaDirectorcurrent2020 — present
PolyProx Therapeutics LtdDirectorcurrent2019 — present
QkineDirector2019 — 2022
PharmEnableDirector2020 — 2022
Bilitech LimitedBoard Observer2018 — 2022
Carrick TherapeuticsBoard Observer2017 — 2022
ConcrBoard Observer2021
APCINTEX LIMITEDBoard Observer2017 — 2021
Z FACTOR LIMITEDDirector2015 — 2021
STORM Therapeutics LimitedBoard Observer2017 — 2019
Biotica Technology LimitedSenior Director, Molecular Biology2009 — 2011
Biotica Technology LimitedDirector, Molecular Biology2003 — 2009
Biotica Technology LimitedProject Leader1999 — 2003
University of CambridgePost Doc1995 — 1999

Investments

Investor

CarrickPhoreMostPolyProXQkineSTORMZ-factor

Per the firm's website.

Colleagues at University of Cambridge Enterprise

Amanda Wooding

Deputy Head of Ventures at University of Cambridge Enterprise

Fatima Kranc

Investment Manager (Life Sciences) at University of Cambridge Enterprise

Gemma Siddall

Investment Associate (Sustainability) at University of Cambridge Enterprise

Leona Hu

Vice President at MPCi (formerly Matrix Partners China)

Loukik Arora

Principal Investment Associate (Life Science) at University of Cambridge Enterprise

Mahesh Santiapillai

Investment Manager (Software and DeepTech) at University of Cambridge Enterprise

Megan Meredith-Rodriguez

Investment Analyst (Deep Tech) at University of Cambridge Enterprise

Piers Horlock

Investment Analyst at University of Cambridge Enterprise

Frequently asked questions

Who is Christine Martin?: Christine Martin is Head of Ventures at Cambridge Enterprise, overseeing investment activities with a focus on life sciences and drug discovery, and has backed University of Cambridge spin-outs including PhoreMost and Qkine. She joined in 2011 after roles in life sciences tech transfer and 11 years at biotech spin-out Biotica, and holds an MA and DPhil from the University of Oxford.
Where does Christine Martin work?: Christine Martin is Head of Ventures at University of Cambridge Enterprise.
What does Christine Martin invest in?: Christine Martin invests in Biotech, Deep Tech.
What companies has Christine Martin invested in?: Investments tracked here include Carrick, PhoreMost, PolyProX, Qkine, STORM, Z-factor.
Where did Christine Martin go to school?: Christine Martin studied at University of Oxford (MA, DPhil, Chemistry).